SUMMARY The effect of bombesin, a possible neurotransmitter of gastrin release, upon gastrin and gastric acid secretion was investigated in 25 patients with duodenal ulcer and in 16 normal subjects. In patients with duodenal ulcer bombesin (10 ng/kg/min) produced an increase in plasma gastrin output (median 22.4 (range 7.5-75.8) pmol/l/min) similar to that obtained in normal subjects (median 24.4 (range 58-56.5) pmol/l/min), whereas gastrin stimulated by a meal was significantly higher in the group of patients with duodenal ulcer (median 20.7 (range 9.2-42.9) vs 16.2 (range 3.422.2) p<0.05). Peak acid output induced by bombesin was significantly higher in patients with duodenal ulcer than in normal subjects (median 24.4 (range 9-0-63.8) vs 14-0 (range 3(0-24.8) mmol/h, p<0.05) despite identical gastrin outputs. The ratio (%) obtained by dividing the acid secretory response to bombesin by the response to pentagastrin, however, was similar in both normal subjects and patients with duodenal ulcer (median 55 (range 20-116) vs 58 (range 31-95) respectively). The difference between the gastrin response to food and bombesin could be explained by the fact that bombesin releases gastrin directly, whereas a protein meal involves several mechanisms (neural, peptidergic, paracrine, endocrine), either stimulatory or inhibitory. The 
directly, whereas a protein meal involves several mechanisms (neural, peptidergic, paracrine, endocrine), either stimulatory or inhibitory. The above results indicate that a higher concentration in antral and/or duodenal gastrin is unlikely to be present in patients with duodenal ulcer. An increased parietal cell mass could explain the higher gastric acid response after bombesin infusion in our group of patients with duodenal ulcer.
Conflicting results have been obtained regarding the gastrin response to a protein meal in normal subjects and patients with duodenal ulcer. Several studies have established that total serum gastrin responses to feeding are higher in patients with duodenal ulcer than in normal subjects. - ,n refer to successive sampling periods (0 = basal sample so AG(1 is always equal to zero).
Gastric acid secretion was calculated as peak acid output (PAO mEq/h). Results are expressed as median plus range values.
As the distribution of the data was skew, the statistical analysis of the results was obtained by means of the Mann-Whitney test, and the Spearman test. A p value less than 5% was accepted.
Results
Gastrin levels promptly increased under bombesin infusion in both groups. The maximal gastrin increment did not significantly differ between normal subjects and patients with duodenal ulcer (median 63.5 (range 20.4-107.6) and 52-8 (range 16.2-144.5) pmol/l respectively; data not shown). A protein meal produced a sustained gastrin response which was significantly higher in patients with duodenal ulcer than in controls: (median 21.7 (range 92-42*9) vs 16.2 (range 3.4-28.2) pmol/l/min), p<005. The rate of gastrin output induced by bombesin was similar in both groups, so that normal subjects showed a bombesin-stimulated gastrin output significantly higher than that induced by meal (median 24.4 (range 5.8-56*5) vs 16-2 (range 34-28.2) pmol/l/min, p<0-05), whereas in patients with duodenal ulcer no significant difference was observed between the gastrin output induced by meal and bombesin (Table) .
No correlation was observed between the gastrin responses to bombesin and to protein meal in both groups (Fig. 1) .
Pentagastrin-stimulated gastric acid secretion was higher than bombesin-induced acid response both in normal subjects (median 20-8 (range 78-36 7) vs Effects of bomnbesin on gastrin and gastric acid secretioni inz patienits with duiodenal ulcer (Fig. 2) . The ratio (%) obtained, however, by dividing the acid secretory response to bombesin by the response to pentagastrin was similar both in normal subjects and patients with duodenal ulcer (median 55 (range 20-116) and 58 (range 31-95)). (Fig. 2) .
Discussion
It has been reported that, after eating, the gastrin response in patients with duodenal ulcer is higher than in normal subjects.' " Our study confirms these data. In normal subjects the infused amphibian polypeptide, bombesin, produced a greater gastrin release than food. In patients with duodenal ulcer, gastrin release did not differ either with bombesin or food. Furthermore, the gastrin response to bombesin was similar in both groups. These results strongly support those studies which have not shown any consistent differences in tissue gastrin content between normal subjects and patients with duodenal ulcer.8
The consumption of food involves several mechanisms (neural, peptidergic, paracrine, endocrine)'6 which control gastrin release. As bombesin acts directly on gastrin release,'2 13 these different mechanisms could explain our results. In 40] 30.
-5 E E 20. Delle.Fave, Kohn, de Magistris, Annibale, Bruizzone, Sparvoli, Severi, and Torsoli fact, no correlation exists between meal and bombesin-induced gastrin outputs in both groups.
Although we did not evaluate the gastrin content in the antrum and duodenum, inconclusive data have been obtained up to the present time.7 x Furthermore, in order to ensure that the above determinations are reliable they should be performed only on surgical specimens; this, of course, was impossible in our study. The gastrin response to bombesin is, however, dose-related'2 13 and it is likely that this response could be correlated with the tissue content: in fact, we infused the maximal gastrin-stimulating dose of bombesin. '3 Thus the differential response to food of our group of patients with duodenal ulcer, compared with normal subjects, does not depend on different gastrin stores. Some hypotheses can be made: bombesin might release different molecular forms of gastrin, in comparison with food, and G cells might be more sensitive to a protein meal, in our group of patients with duodenal ulcer.
It is well known that patients with duodenal ulcer have a higher acid response to pentagastrin than normal subjects: 17 our results of gastric acid secretion confirm these data. This secretory pattern occurs even with intravenous bombesin, despite similar gastrin outputs. Bombesin stimulates gastric acid secretion less than pentagastrin in normal subjects."' Our data show that even in patients with duodenal ulcer bombesin is less potent than pentagastrin. These results do not confirm those reported by others, 8 who showed in eight patients with duodenal ulcer similar acid secretory responses after bombesin and pentagastrin. The discrepancy could be explained either by the different method of drug administration, and the different dose of bombesin used, or by the small and selected number of patients studied. The different secretory response to bombesin between normal subjects and patients with duodenal ulcer, the gastrin response being identical, is likely to be because of an increased secretory rate in our group of patients with duodenal ulcer. In fact, if we express the gastric acid response to bombesin as the percentage of the acid response to pentagastrin, no difference is found in both groups.
An increased parietal cell mass has been reported in patients with duodenal ulcer.'9 21) In our opinion these results can be explained by the abovementioned studies. An 
